Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 5
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
The Reply.
Stüssi-Helbling M, Arrigo M, Huber LC. Stüssi-Helbling M, et al. Am J Med. 2020 Feb;133(2):e64. doi: 10.1016/j.amjmed.2019.09.004. Am J Med. 2020. PMID: 31954478 No abstract available.
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Heijnen IAFM, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci MR, Huber LC, Stüssi-Helbling M, Albrich WC, Sendi P, Osthoff M. Urwyler P, et al. Among authors: stussi helbling m. Front Immunol. 2023 Oct 27;14:1255292. doi: 10.3389/fimmu.2023.1255292. eCollection 2023. Front Immunol. 2023. PMID: 37965347 Free PMC article. Clinical Trial.
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.
Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Nilsson J, Held U, Puhan MA, Boyman O. Cervia C, et al. Among authors: stussi helbling m. Nat Commun. 2022 Jan 25;13(1):446. doi: 10.1038/s41467-021-27797-1. Nat Commun. 2022. PMID: 35078982 Free PMC article.
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.
Taeschler P, Cervia C, Zurbuchen Y, Hasler S, Pou C, Tan Z, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Brodin P, Nilsson J, Probst-Müller E, Boyman O. Taeschler P, et al. Among authors: stussi helbling m. Allergy. 2022 Aug;77(8):2415-2430. doi: 10.1111/all.15302. Epub 2022 Apr 8. Allergy. 2022. PMID: 35364615 Free PMC article.
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
Taeschler P, Adamo S, Deng Y, Cervia C, Zurbuchen Y, Chevrier S, Raeber ME, Hasler S, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Bodenmiller B, Boyman O, Nilsson J. Taeschler P, et al. Among authors: stussi helbling m. Allergy. 2022 Aug;77(8):2468-2481. doi: 10.1111/all.15372. Epub 2022 Jun 2. Allergy. 2022. PMID: 35567391 Free PMC article.
A distinct innate immune signature marks progression from mild to severe COVID-19.
Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, Sivapatham S, Jacobs A, Bachli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Nilsson J, Boyman O, Bodenmiller B. Chevrier S, et al. Among authors: stussi helbling m. Cell Rep Med. 2020 Dec 26;2(1):100166. doi: 10.1016/j.xcrm.2020.100166. eCollection 2021 Jan 19. Cell Rep Med. 2020. PMID: 33521697 Free PMC article.
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.
Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, Sivapatham S, Jacobs A, Baechli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Bodenmiller B, Boyman O, Nilsson J. Adamo S, et al. Among authors: stussi helbling m. Allergy. 2021 Sep;76(9):2866-2881. doi: 10.1111/all.14866. Epub 2021 Jun 30. Allergy. 2021. PMID: 33884644 Free PMC article.
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, Raeber ME, Adamo S, Weigang S, Emmenegger M, Hasler S, Bosshard PP, De Cecco E, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Zinkernagel AS, Schaer DJ, Aguzzi A, Kochs G, Held U, Probst-Müller E, Rampini SK, Boyman O. Cervia C, et al. Among authors: stussi helbling m. J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. Epub 2020 Nov 20. J Allergy Clin Immunol. 2021. PMID: 33221383 Free PMC article.
13 results